Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONCT

Oncternal Therapeutics (ONCT) Stock Price, News & Analysis

Oncternal Therapeutics logo

About Oncternal Therapeutics Stock (NASDAQ:ONCT)

Advanced Chart

Key Stats

Today's Range
$0.53
$0.53
50-Day Range
$0.53
$0.53
52-Week Range
$0.53
$7.77
Volume
N/A
Average Volume
93,010 shs
Market Capitalization
$1.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Hold

Company Overview

Receive ONCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ONCT Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Oncternal Therapeutics Reports Q3 2024 Earnings
See More Headlines

ONCT Stock Analysis - Frequently Asked Questions

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) released its quarterly earnings results on Thursday, August, 8th. The company reported ($2.89) EPS for the quarter, topping analysts' consensus estimates of ($3.03) by $0.14. The company had revenue of $0.80 million for the quarter, compared to the consensus estimate of $0.24 million. Oncternal Therapeutics had a negative net margin of 1,599.95% and a negative trailing twelve-month return on equity of 177.58%.
Read the conference call transcript
.

Shares of Oncternal Therapeutics reverse split before market open on Monday, January 8th 2024.The 1-20 reverse split was announced on Monday, January 8th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 8th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncternal Therapeutics investors own include NIO (NIO), Walt Disney (DIS), Tesla (TSLA), Plug Power (PLUG), Meta Platforms (META) and Moderna (MRNA).

Company Calendar

Last Earnings
8/08/2024
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONCT
CIK
1260990
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$2.00
Potential Upside/Downside
+1,799.0%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($11.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.48 million
Net Margins
-1,599.95%
Pretax Margin
-1,599.95%
Return on Equity
-177.58%
Return on Assets
-131.30%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.39
Quick Ratio
2.39

Sales & Book Value

Annual Sales
$790 thousand
Price / Sales
1.97
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.19 per share
Price / Book
0.05

Miscellaneous

Outstanding Shares
2,960,000
Free Float
2,628,000
Market Cap
$1.56 million
Optionable
No Data
Beta
1.18
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ONCT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners